Page 44 - நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Combination of drugs promising for brain tumor treatment Results from a phase 1 clinical trial suggests that the immunotherapy drug and new precision drug work together to attack the tumor and reduce the cancer in some patients. By iStock Story at a glance Researchers are testing out a combination of two drugs as a treatment for an aggressive type of brain cancer called glioblastoma. These drugs target the immune system and allow it to target the tumor. A phase 1 clinical trial shows promising results from two patients. Glioblastoma is a type of cancer that can form in the brain or spinal cord. The drugs used in the clinical trial are atezolizumab, an immunotherapy drug, and ipatasertib, a new precision drug that “may be able to uncloak tumours to the immune system,” according to a statement from the Institute of Cancer Research, London.

United statesCity ofUnited kingdomJuanita lopezInstitute of cancer researchFood drug administrationCancer researchClinical researcherAdd changing americaDrug administrationJohann de bonoExperimental cancer medicineஒன்றுபட்டது மாநிலங்களில்நகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்வநீட லோபஸ்